The effects of mGlu7 receptor modulation in behavioural models sensitive to antidepressant action in two mouse strains

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Behavioural Pharmacology

• Publication date

  2013-04-01

• Fields of study

  Medicine, Chemistry, Psychology

• Identifiers
  DOI 10.1097/FBP.0b013e32835efc78PMID 23455446
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A selective mGlu7 receptor antagonist MMPIP reversed antidepressant-like effects of AMN082 in rats.

  2013cited by this paper
• Pharmacological interference with metabotropic glutamate receptor subtype 7 but not subtype 5 differentially affects within- and between-session extinction of Pavlovian conditioned fear.

  2012cited by this paper
• Pharmacological modulation of mGluR7 with AMN082 and MMPIP exerts specific influences on alcohol consumption and preference in rats

  2012influential reference
• The mGluR7 allosteric agonist AMN082 produces antidepressant-like effects by modulating glutamatergic signaling.

  2012cited by this paper
• Cross-national epidemiology of DSM-IV major depressive episode

  2011influential reference
• The Metabotropic Glutamate Receptor 7 Allosteric Modulator AMN082: A Monoaminergic Agent in Disguise?

  2011cited by this paper
• High-fat diet selectively protects against the effects of chronic social stress in the mouse.

  2011cited by this paper
• Effects of a novel metabotropic glutamate receptor 7 negative allosteric modulator, 6-(4-methoxyphenyl)-5-methyl-3-pyridin-4-ylisoxazonolo[4,5-c]pyridin-4(5H)-one (MMPIP), on the central nervous system in rodents.

  2010influential reference
• mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists

  2010influential reference
• Metabotropic glutamate receptor 7: at the interface of cognition and emotion.

  2010cited by this paper
• The effect of mGlu8 deficiency in animal models of psychiatric diseases

  2010cited by this paper
• A Glutamate Pathway to Faster-Acting Antidepressants?

  2010cited by this paper
• Rapid onset of antidepressant action: a new paradigm in the research and treatment of major depressive disorder.

  2008cited by this paper
• Chapter 4.4 The glutamatergic system as a potential therapeutic target for the treatment of anxiety disorders

  2008cited by this paper
• Amygdaloid metabotropic glutamate receptor subtype 7 is involved in the acquisition of conditioned fear

  2008cited by this paper
• Combined administration of PHCCC, a positive allosteric modulator of mGlu4 receptors and ACPT-I, mGlu III receptor agonist evokes antidepressant-like effects in rats

  2007influential reference
• In Vitro Pharmacological Characterization of Novel Isoxazolopyridone Derivatives as Allosteric Metabotropic Glutamate Receptor 7 Antagonists

  2007cited by this paper
• Activation of the mGlu7 receptor elicits antidepressant-like effects in mice

  2007cited by this paper
• Feeling Strained? Influence of Genetic Background on Depression-Related Behavior in Mice: A Review

  2007cited by this paper
• Metabotropic Glutamate Receptor Subtype 7 Ablation Causes Dysregulation of the HPA Axis and Increases Hippocampal BDNF Protein Levels: Implications for Stress-Related Psychiatric Disorders

  2006cited by this paper
• New approaches to antidepressant drug discovery: beyond monoamines

  2006cited by this paper
• The glutamate transporter GLAST is involved in spinal nociceptive processing.

  2006cited by this paper
• A selective metabotropic glutamate receptor 7 agonist: activation of receptor signaling via an allosteric site modulates stress parameters in vivo.

  2005cited by this paper
• Stress and the brain: from adaptation to disease

  2005cited by this paper
• Metabotropic glutamate receptors as novel targets for anxiety and stress disorders

  2005cited by this paper
• Distinguishing roles for norepinephrine and serotonin in the behavioral effects of antidepressant drugs.

  2004cited by this paper
• Effects of amitriptyline on serum glutamate and free tryptophan in rats

  2004cited by this paper
• Incidence and duration of side effects and those rated as bothersome with selective serotonin reuptake inhibitor treatment for depression: patient report versus physician estimate.

  2004cited by this paper
• Subtype-specific alterations of gamma-aminobutyric acid and glutamate in patients with major depression.

  2004cited by this paper
• From monoamines to genomic targets: a paradigm shift for drug discovery in depression

  2004cited by this paper
• Withdrawal from chronic amphetamine induces depressive-like behavioral effects in rodents.

  2003cited by this paper
• Physiological Roles and Therapeutic Potential of Metabotropic Glutamate Receptors

  2003cited by this paper
• The economic burden of depression in the United States: how did it change between 1990 and 2000?

  2003cited by this paper
• Diagnosis and definition of treatment-resistant depression.

  2003cited by this paper
• Use of Dopamine-β-hydroxylase-Deficient Mice to Determine the Role of Norepinephrine in the Mechanism of Action of Antidepressant Drugs

  2001cited by this paper
• Behavioral phenotyping of transgenic and knockout mice: experimental design and evaluation of general health, sensory functions, motor abilities, and specific behavioral tests.

  1999cited by this paper
• Acute application of the tricyclic antidepressant desipramine presynaptically stimulates the exocytosis of glutamate in the hippocampus.

  1999cited by this paper
• Effect of antidepressant drugs on veratridine-evoked glutamate and aspartate release in rat prefrontal cortex.

  1999cited by this paper
• Antidepressant efficacy and tolerability of the selective norepinephrine reuptake inhibitor reboxetine: a review.

  1998cited by this paper
• Pharmacology and functions of metabotropic glutamate receptors.

  1997cited by this paper
• Glucocorticoids and the Genesis of Depressive Illness a Psychobiological Model

  1994cited by this paper
• The neocortex

  1994cited by this paper
• A rational approach to the non‐responding depressed patient

  1993cited by this paper
• Amitriptyline Prevents N‐Methyl‐D‐Aspartate (NMDA)‐Induced Toxicity, Does Not Prevent NMDA‐Induced Elevations of Extracellular Glutamate, but Augments Kainate‐Induced Elevations of Glutamate

  1992cited by this paper
• Diagnostic value of dexamethasone suppression test in depression.

  1980cited by this paper
• The psychotropic effects of cycloserine: A new use for an antibiotic

  1961cited by this paper

• Allosteric Modulators of Metabotropic Glutamate Receptors as Novel Therapeutics for Neuropsychiatric Disease

  2022cites this paper
• Clinical investigations of compounds targeting metabotropic glutamate receptors.

  2022cites this paper
• mGlu Receptor Modulation in Murine Models of Stress and Affective Disorders

  2021cites this paper
• LSP2-9166, an orthosteric mGlu4 and mGlu7 receptor agonist, reduces cocaine self-administration under a progressive ratio schedule in rats.

  2020cites this paper
• International Union of Basic and Clinical Pharmacology. CXI. Pharmacology, Signaling, and Physiology of Metabotropic Glutamate Receptors

  2020cites this paper
• Serum Metabolic Profiling Reveals the Antidepressive Effects of the Total Iridoids of Valeriana jatamansi Jones on Chronic Unpredictable Mild Stress Mice

  2020cites this paper
• The Modulation of Pain by Metabotropic Glutamate Receptors 7 and 8 in the Dorsal Striatum

  2019cites this paper
• Brain metabonomics study of the antidepressant-like effect of Xiaoyaosan on the CUMS-depression rats by 1H NMR analysis.

  2019cites this paper
• Metabotropic Glutamate Receptors and Neurological/Psychiatric Disorders

  2019cites this paper
• Targeting of Metabotropic Glutamate Receptors for the Development of Novel Antidepressants

  2019cites this paper
• The potential antidepressant action and adverse effects profile of scopolamine co‐administered with the mGlu7 receptor allosteric agonist AMN082 in mice

  2018cites this paper
• mGlu receptors as potential targets for novel antidepressants

  2018cites this paper
• Increased amygdalar metabotropic glutamate receptor 7 mRNA in a genetic mouse model of impaired fear extinction

  2018cites this paper
• Metabotropic Glutamate Receptor 7: A New Therapeutic Target in Neurodevelopmental Disorders

  2018influential citation
• Metabotropic Glutamate Receptor 7 (mGluR7) as a Target for Modulating Pain-evoked Activities of Neurons in the Hippocampal CA3 Region of Rats.

  2017cites this paper
• Metabotropic Glutamate Receptors – Regulation of Acute and Chronic Stress-Related Behavior and Physiology

  2017cites this paper
• Relief from detrimental consequences of chronic psychosocial stress in mice deficient for the metabotropic glutamate receptor subtype 7

  2017cites this paper
• Glutamate-Based Drug Discovery for Novel Antidepressants

  2016cites this paper
• The Emerging Role of Metabotropic Glutamate Receptors in the Pathophysiology of Chronic Stress-Related Disorders

  2016cites this paper
• Functional Aspects of Peripheral and Spinal Cord Neurons Involved in Itch and Pain

  2016cites this paper
• Metabotropic Glutamate Receptors in Central Nervous System Diseases.

  2016cites this paper
• Functional Aspects of Peripheral and Spinal Cord Neurons Involved in Itch and Pain

  2016cites this paper
• A novel mGlu4 selective agonist LSP4-2022 increases behavioral despair in mouse models of antidepressant action.

  2015cites this paper
• Potential of Glutamate-Based Drug Discovery for Next Generation Antidepressants

  2015cites this paper
• Negative allosteric modulation of the mGlu7 receptor reduces visceral hypersensitivity in a stress-sensitive rat strain

  2015cites this paper
• Metabotropic Glutamate Receptor 7 (mGluR7) as a Target for the Treatment of Psychostimulant Dependence.

  2015cites this paper
• Faster, better, stronger: towards new antidepressant therapeutic strategies.

  2015cites this paper
• Investigating group III metabotropic glutamate receptors as novel therapeutic targets in Parkinson's disease and Levodopa-induced dyskinesia

  2014cites this paper
• P-glycoprotein Inhibition Increases the Brain Distribution and Antidepressant-Like Activity of Escitalopram in Rodents

  2013cites this paper
• Antidepressant effects of ketamine: mechanisms underlying fast-acting novel antidepressants

  2013cites this paper
• Adult siRNA-induced knockdown of mGlu7 receptors reduces anxiety in the mouse.

  2013influential citation